Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,747,845
-
Total 13F shares
-
1,351,550
-
Share change
-
+29,390
-
Total reported value
-
$6,609,000
-
Price per share
-
$4.89
-
Number of holders
-
15
-
Value change
-
+$136,417
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q1 2022
As of 31 Mar 2022,
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,351,550 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, EDGEWOOD MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, SYNOVUS FINANCIAL CORP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and SeaCrest Wealth Management, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.